skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search

Recent Searches

Clear all Searches

Relevant Insights

Featured Content

view all search results
Search Close
Hamburger
profile Icon for Mobile

Scott B. McBride

Partner

New Jersey
T: +1 973.597.6136 F: +1 973.597.2400 smcbride@lowenstein.com
  • BIO
  • EXPERIENCE
  • HONORS & AWARDS
  • NEWS & INSIGHTS

See more section

Scott McBride has what white collar defendants need most: a deep understanding of how the system works. An Assistant U.S. Attorney for over a decade, he combines that knowledge with formidable courtroom skill to provide clients with a defense that is equal parts judicious and tenacious.

Scott focuses his practice on matters of government, securities, financial, and health care fraud; Foreign Corrupt Practices Act violations; and civil business litigation, leveraging the experience gained from more than 10 years in the U.S. Attorney's Office in Newark, New Jersey. He investigated and prosecuted a broad range of white collar criminal offenses there, serving as Deputy Chief of the Economic Crimes Unit and as a member of the Health Care & Government Fraud Unit. He also prosecuted numerous cases involving cybercrime, identity theft, and intellectual property-related offenses, as well as tax evasion and public corruption.

Scott also has significant civil litigation experience in both the private and public sectors.

Prior to joining the U.S. Attorney's Office, Scott completed federal clerkships under the Honorable Jose L. Linares and the Honorable Ronald J. Hedges, both of the United States District Court for the District of New Jersey.

  • Represent employees of multinational medical device company in relation to investigation by SEC into alleged violations of Foreign Corrupt Practices Act (FCPA) in Vietnam.
  • Represent a multinational pharmaceutical and life sciences company in an internal investigation concerning self-dealing and misappropriation of intellectual property at biotech subsidiary.
  • Represented intervenor in judgment enforcement action in Southern District of New York stemming from $146M defamation default judgment and damages verdict in U.S. District Court for the District of Columbia.
  • Represented former corporate controller and nine other employees of publicly traded software company in an SEC investigation into the company’s recognition of software licensing and SaaS revenue over the course of several years. Favorably settled the case for the corporate controller with a small civil monetary penalty and outright dismissal of claims alleging knowing misconduct—without admitting the merit of a single books-and-records allegation of “unreasonable” accounting judgment. No other client-employees, including those identified as “subjects” in the DOJ’s parallel investigation, were charged.
  • Secured a successful plea agreement and sentence of probation for medical marijuana dispenser and real estate investor charged by U.S. Department of Justice with marijuana distribution conspiracy and money laundering on dark web.
  • Secured a successful plea agreement and sentence of probation for pharmaceutical representative charged by the U.S. Department of Justice with health care fraud conspiracy in connection with $53 million scheme to defraud state and private health insurance plans through fraudulent compound medication prescriptions.
  • Represented the chief compliance officer of a major opioid manufacturer in connection with an investigation by the U.S. Department of Justice, Drug Enforcement Administration, and the Pennsylvania Attorney General’s Office concerning alleged civil and criminal violations of the Controlled Substances Act related to opioid diversion, misbranding violations under the Federal Food, Drug & Cosmetics Act, and violations of the federal anti-kickback statute relating to manufacturer speaker programs and use of savings cards.
  • Represented a specialty pharmacy in connection with an investigation by the U.S. Department of Justice; Drug Enforcement Administration; and U.S. Department of Health & Human Services, Office of Inspector General, into alleged violations of the Controlled Substances Act and federal anti-kickback statute in connection with dispensing of transmucosal immediate release fentanyl (TIRF) and other controlled substances for pain.
SEE MORE

CLICK HERE FOR AWARD INFORMATION & METHODOLOGY

No aspect of these advertisements has been approved by the highest court of any state.

Education

  • Georgetown University Law Center (J.D. 2002)

    Georgetown University, School of Business (B.S. 1997), Finance and Government

Affiliations

  • Summit Speech School, New Providence, NJ
    • Trustee, Board of Trustees
  • McBride Enterprises, Inc., Franklin Lakes, NJ
    • Member, Board of Directors

Admissions

  • New York
  • New Jersey
  • District of Columbia

Related Areas

Subscribe